Vitamin D supplementation in the ICU patient

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 2, 2015, Pages 187-192

  Christopher, Kenneth B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Critical care; Outcomes; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; VITAMIN D; BIOLOGICAL MARKER; VITAMIN;

ARTICLE; CLINICAL STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG SAFETY; ERYTHEMA; HUMAN; HYPERCALCEMIA; IMMUNOASSAY; INTENSIVE CARE; INTENSIVE CARE UNIT; INTERVENTION STUDY; META ANALYSIS (TOPIC); MORTALITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BIOSYNTHESIS; BLOOD; DIET SUPPLEMENTATION; DIET THERAPY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CHOLECALCIFEROL; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; HUMANS; INTENSIVE CARE UNITS; NUTRITION THERAPY; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84922677929     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000147     Document Type: Article

References (80)

1. Purtle SW, Moromizato T, McKane CK, et al. The association of red cell distribution width at hospital discharge and out-of-hospital mortality following critical illness. Crit Care Med 2014; 42:918-929.
2. Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 2010; 38:1276-1283.
3. Herring AA, Ginde AA, Fahimi J, et al. Increasing critical care admissions from U.S. emergency departments, 2001-2009. Crit Care Med 2013; 41:1197-1204.
4. Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med 2010; 38:65-71.
5. Wunsch H, Guerra C, Barnato AE, et al. Three-year outcomes for Medicare beneficiaries who survive intensive care. J Am Med Assoc 2010; 303:849-856.
6. Elliott D, McKinley S, Alison J, et al. Health-related quality of life and physical recovery after a critical illness: a multicentre randomised controlled trial of a home-based physical rehabilitation program. Crit Care 2011; 15:R142.
7. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58.
8. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-1930.
9. Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013; 369:1991-2000.
10. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 2010; 85:752-757; quiz 757-758.
11. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocrine Rev 2012; 33:456-492.
12. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94:26-34.
13. Verstuyf A, Carmeliet G, Bouillon R, et al. Vitamin D: a pleiotropic hormone. Kidney Int 2010; 78:140-145.
14. Bikle DD. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 2010; 21:375-384.
15. Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183:5458-5467.
16. Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 2009; 16:41-47.
17. Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009; 4:e5810.
18. Doss M, White MR, Tecle T, et al. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 2010; 87:79-92.
19. Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6:231-243.
20. Kempker JA, Tangpricha V, Ziegler TR, et al. Vitamin D in sepsis: from basic science to clinical impact. Crit Care 2012; 16:316.
21. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014; 7:69-87.
22. Krishnan A, Venkatesh B. Vitamin D measurement in the intensive care unit: methodology, clinical relevance and interpretation of a random value. Inflamm Allergy Drug Targets 2013; 12:230-238.
23. van den Ouweland JM, Beijers AM, Demacker PN, et al. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878 (15- 16):1163-1168.
24. Heijboer AC, Blankenstein MA, Kema IP, et al. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012; 58:543-548.
25. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011; 12:19-28.
26. Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and antimicrobial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7:28.
27. de la Hunty A, Wallace AM, Gibson S, et al. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 2010; 104:612-619.
28. Carter GD. 25-hydroxyvitamin D: a difficult analyte. Clin Chem 2012; 58:486-488.
29. Zittermann A, Iodice S, Pilz S, et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95:91-100.
30. Searing DA, Leung DY. Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin N Am 2010; 30:397-409.
31. Schottker B, Jorde R, Peasey A, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. Br Med J 2014; 348:g3656.
32. Levin GP, Robinson-Cohen C, de Boer IH, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. J Am Med Assoc 2012; 308:1898-1905.
33. Ginde AA, Camargo CA Jr, Shapiro NI. Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. Acad Emerg Med 2011; 18:551-554.
34. Lange N, Litonjua AA, Gibbons FK, et al. Prehospital vitamin D concentration, mortality, and bloodstream infection in a hospitalized patient population. Am J Med 2013; 126:640 e619-627.
35. Bacon CJ, Gamble GD, Horne AM, et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009; 20:1407-1415.
36. Burton JM, Kimball S, Vieth R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010; 74:1852-1859.
37. Castro M, King TS, Kunselman SJ, et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. J Am Med Assoc 2014; 311:2083-2091.
38. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012; 156:105-114.
39. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. J Am Med Assoc 2012; 308:1333-1339.
40. von Restorff C, Bischoff-Ferrari HA, Theiler R. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 2009; 45:747-749.
41. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179:843-850.
42. Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010; 53:2112-2119.
43. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 2012; 109:15449-15454.
44. Bergman P, Norlin AC, Hansen S, et al. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. Br Med J open 2012; 2:e001663.
45. Salahuddin N, Ali F, Hasan Z, et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis 2013; 13:22.
46. Marchisio P, Consonni D, Baggi E, et al. Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J 2013; 32:1055-1060.
47. Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. Am J Clin Nutr 2010; 91:1255-1260.
48. Leaf DE, Raed A, Donnino MW, et al. Randomized controlled trial of calcitriol in severe sepsis. Am J Respir Crit Care Med 2014; 190:533-541.
49. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. J Am Med Assoc 2010; 303:1815-1822.
50. Amrein K, Venkatesh B. Vitamin D and the critically ill patient. Curr Opin Clin Nutr Metab Care 2012; 15:188-193.
51. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360:1912-1914.
52. Nair P, Lee P, Reynolds C, et al. Significant perturbation of vitamin D-parathyroid-calcium axis and adverse clinical outcomes in critically ill patients. Intensive Care Med 2013; 39:267-274.
53. Sauneuf B, Brunet J, Lucidarme O, et al. Prevalence and risk factors of vitamin D deficiency in critically ill patients. Inflamm Allergy Drug Targets 2013; 12:223-229.
54. Lucidarme O, Messai E, Mazzoni T, et al. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med 2010; 36:1609-1611.
55. Braun A, Chang D, Mahadevappa K, et al. Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med 2011; 39:671-677.
56. Matthews LR, Ahmed Y, Wilson KL, et al. Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am J Surg 2012; 204:37-43.
57. Braun AB, Gibbons FK, Litonjua AA, et al. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 2012; 40:63-72.
58. Braun AB, Litonjua AA, Moromizato T, et al. Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill. Crit Care Med 2012; 40:3170-3179.
59. Arnson Y, Gringauz I, Itzhaky D, et al. Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients. QJM 2012; 105:633-639.
60. McKinney JD,BaileyBA, Garrett LH, et al. Relationshipbetween vitaminDstatus and ICU outcomes in veterans. J Am Med Dir Assoc 2011; 12:208-211.
61. Venkatram S, Chilimuri S, Adrish M, et al. Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care 2011; 15:R292.
62. Quraishi SA, Bittner EA, Blum L, et al. Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med 2014; 42:1365-1371.
63. Amrein K, Zajic P, Schnedl C, et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit Care 2014; 18:R47.
64. Moromizato T, Litonjua AA, Braun AB, et al. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med 2014; 42:97-107.
65. Lee P. Vitamin D metabolism and deficiency in critical illness. Best Pract Res Clin Endocrinol Metab 2011; 25:769-781.
66. Lee P, Nair P, Eisman JA, et al. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med 2009; 35:2028-2032.
67. van den Berghe G, Van Roosbroeck D, Vanhove P, et al. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003; 88:4623-4632.
68. Ingels CM, Van Cromphaut SJ, Wouters PJ, et al. Effect of restoration of 25OHD3 status in prolonged critical illness on serum innate immunity parameters LL-37 and sCD163. Crit Care 2010; 14 (Suppl 1):590.
69. Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera C, et al. Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method. J Steroid Biochem Mol Biol 2010; 121:452-455.
70. Amrein K, Sourij H, Wagner G, et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, doubleblind, placebo-controlled pilot study. Crit Care 2011; 15:R104.
71. Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. J Am Med Assoc 2014; 312:1520-1530.
72. Hollis BW, Wagner CL. Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013; 98:4619-4628.
73. Ross AC, Taylor CL, Yaktine AL, et al. Dietary reference intakes for calcium and vitamin D. Washington, DC: Institute of Medicine, The National Academies Press; 2011.
74. Hollis BW. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am 2010; 39:271-286.
75. Amrein K, Quraishi SA, Litonjua AA, et al. Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab 2014; 99:1461-1469.
76. Lee P, Greenfield JR, Seibel MJ, et al. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 2009; 122:1056-1060.
77. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19:2739-2745.
78. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376:180-188.
79. Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multitrace element products. Nutr Clin Pract 2012; 27:440-491.
80. Cipriani C, Romagnoli E, Pepe J, et al. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab 2013; 98:2709-2715.